Pharmaceutical manufacturing generates wastewater containing active pharmaceutical ingredients (APIs), solvents, intermediates, and cleaning agents that pose serious environmental and public health risks if improperly treated. The presence of antibiotics, hormones, and cytotoxic compounds requires specialized treatment beyond conventional biological methods.
Pharmaceutical wastewater is characterized by high variability in composition and flow (due to batch production), low biodegradability of synthetic drug compounds, and the presence of antimicrobial substances that can inhibit biological treatment processes. Increasingly, regulators worldwide are imposing stricter limits on pharmaceutical residues in effluent discharge.
Zhongsheng Environmental provides purpose-built treatment systems for the pharmaceutical industry, combining advanced oxidation with robust biological processes to achieve complete degradation of APIs and regulatory compliance, while meeting the stringent documentation and quality requirements expected in pharmaceutical manufacturing.
Active Pharmaceutical Ingredients: APIs including antibiotics, hormones, and anti-cancer drugs persist through conventional treatment and can cause antimicrobial resistance and ecological damage at very low concentrations (ng/L to μg/L).
Solvent & Chemical Residues: Organic solvents (methanol, acetone, dichloromethane), catalysts, and reagents from synthesis processes create high COD loads and may be toxic to biological treatment.
Antimicrobial Inhibition: Antibiotic residues can kill or suppress the microorganisms essential for biological wastewater treatment, requiring pre-treatment to reduce antimicrobial activity before biological stages.
Regulatory Compliance: Pharmaceutical facilities face the strictest discharge standards globally, with emerging regulations specifically targeting API residues and requiring documented treatment validation.
Advanced treatment approach for pharmaceutical wastewater
High-concentration solvent streams are segregated for distillation recovery, reducing COD load by 60–80% before treatment. Concentrated mother liquors are pre-treated separately.
Fenton oxidation, ozonation, or UV/H₂O₂ breaks down refractory APIs and destroys antimicrobial activity, improving biodegradability (BOD/COD ratio) from 0.1 to above 0.4.
Membrane bioreactor with extended sludge retention time (30–60 days) provides enhanced biodegradation of pharmaceutical compounds. MBR effluent meets strict TSS and turbidity requirements.
Granular activated carbon (GAC) adsorbs residual trace APIs, followed by nanofiltration/RO for water reuse applications. API removal exceeds 99.9%.
High-standard wastewater treatment equipment for pharmaceutical plants
Integrated MBR membrane bioreactor system combining activated sludge treatment with submerged PVDF membrane filtration. Delivers near-reuse-quality effluent (<1 μm filtration) with 60% smaller footprint than conventional systems. Ideal for municipal sewage, industrial process water, and water reuse projects from 10 to 2,000 m³/day.
DF series PVDF flat sheet membrane modules for submerged MBR applications. Features 0.1 μm pore size with integrated aeration box for continuous membrane scouring. Individually replaceable membrane elements, stainless steel frame, and 10–20× lower energy consumption than external cross-flow systems. Available in 80–225 m² configurations producing 32–135 m³/day.
Zhongsheng Environmental industrial RO systems deliver ultra-pure permeate at recovery rates up to 95%, serving pharmaceutical, semiconductor, food & beverage, and power generation applications worldwide. Fully automated PLC-controlled operation with continuous output and minimal chemical consumption.
The ZS Series Chlorine Dioxide Generator produces high-purity ClO₂ disinfectant on-site using proven chemical or electrolytic methods. Available in eight configurations — from compact manual units (50 g/h) to fully automated industrial systems (20,000 g/h) — these generators deliver reliable microbial control for municipal drinking water, hospital effluent, industrial cooling loops, and process wastewater. Compliant with EPA, EU Drinking Water Directive 98/83/EC, and WHO Guidelines for Drinking-water Quality.
The ZS-L Series Medical Wastewater Treatment System is a compact, fully automated unit engineered for clinics, dental offices, veterinary hospitals, and small medical facilities. Combining multi-stage filtration with ozone disinfection (99%+ kill rate), it meets EPA and EU Urban Waste Water Directive 91/271/EEC discharge requirements in a footprint as small as 0.5 m² — with no chemical dosing, no noise, and no secondary pollution.
Our engineers understand the unique requirements of pharmaceutical wastewater. Get a free consultation with detailed API removal guarantees.
